BTI-322 for acute rejection after renal transplantation

Transplant Proc. 1997 Aug;29(5):2353. doi: 10.1016/s0041-1345(97)00398-9.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • CD2 Antigens / immunology
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • Humans
  • Kidney Transplantation*
  • Rats
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • CD2 Antigens
  • LO-CD2a